| Enzo |
ALX-260-143-R020 |
Z-VEID-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-142-R100 |
Z-LEVD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-134-M005 |
Z-Phe-Tyr(tBu)-diazomethylketone
|
5mg |
|
|
| Enzo |
ALX-260-134-M001 |
Z-Phe-Tyr(tBu)-diazomethylketone
|
1mg |
|
|
| Enzo |
ALX-260-137-M005 |
HDAC substrate (fluorogenic)
|
5mg |
|
|
| Enzo |
ALX-260-141-R100 |
Z-DEVD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-141-R020 |
Z-DEVD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-140-R100 |
Z-WEHD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-140-R020 |
Z-WEHD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-139-R100 |
Z-VDVAD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-138-R020 |
Z-VAD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-139-R020 |
Z-VDVAD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-138-R100 |
Z-VAD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-137-M001 |
HDAC substrate (fluorogenic)
|
1mg |
|
|
| Enzo |
ALX-260-130-M005 |
Z-Phe-Arg-pNA . hydrochloride
|
5mg |
|
|
| Enzo |
ALX-260-133-M001 |
N-(1-Naphthalenylsulfonyl)-Ile-Trp-aldehyde
|
1mg |
|
|
| Enzo |
ALX-260-133-M005 |
N-(1-Naphthalenylsulfonyl)-Ile-Trp-aldehyde
|
5mg |
|
|
| Enzo |
ALX-260-128-M005 |
Actinonin
|
5mg |
|
|
| Enzo |
ALX-260-129-M005 |
Z-Phe-Arg-AFC . trifluoroacetate
|
5mg |
|
|
| Enzo |
ALX-260-127-M001 |
gamma Secretase inhibitor
|
1mg |
|
|
| Enzo |
ALX-260-123-M001 |
Mca-Pro-Leu-Ala-Nva-Dap(Dnp)-Ala-Arg-NH2
|
1mg |
|
|
| Enzo |
ALX-260-120-M005 |
Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH
|
5mg |
|
|
| Enzo |
ALX-260-121-M001 |
Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2
|
1mg |
|
|
| Enzo |
ALX-260-118-M005 |
Ac-LETD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-118-M010 |
Ac-LETD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-117-M010 |
Ac-WEHD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-117-M005 |
Ac-WEHD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-110-M010 |
Ac-IETD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-110-M005 |
Ac-IETD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-111-M010 |
Ac-VEID-AFC
|
10mg |
|
|
| Enzo |
ALX-260-116-M005 |
Ac-LEHD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-116-M010 |
Ac-LEHD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-112-M005 |
Ac-VDVAD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-112-M010 |
Ac-VDVAD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-111-M005 |
Ac-VEID-AFC
|
5mg |
|
|
| Enzo |
ALX-260-109-M005 |
Ac-VAD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-108-M010 |
Ac-YVAD-AFC
|
10mg |
|
|
| Enzo |
ALX-260-102-M001 |
Z-LE(OMe)TD(OMe)-FMK
|
1mg |
|
|
| Enzo |
ALX-260-108-M005 |
Ac-YVAD-AFC
|
5mg |
|
|
| Enzo |
ALX-260-099-M001 |
Z-VD(OMe)VAD(OMe)-FMK
|
1mg |
|
|
| Enzo |
ALX-260-098-M001 |
Biotinyl-VAD(OMe)-FMK
|
1mg |
|
|
| Enzo |
ALX-260-094-5001 |
D2R (high purity)
|
1mg |
|
|
| Enzo |
ALX-260-093-M025 |
Antipain
|
25mg |
|
|
| Enzo |
ALX-260-093-M005 |
Antipain
|
5mg |
|
|
| Enzo |
ALX-260-091-M001 |
MG-115
|
1mg |
|
|
| Enzo |
ALX-260-091-M005 |
MG-115
|
5mg |
|
|
| Enzo |
ALX-260-090-M005 |
Proteasome inhibitor II (aldehyde)
|
5mg |
|
|
| Enzo |
ALX-260-090-M001 |
Proteasome inhibitor II (aldehyde)
|
1mg |
|
|
| Enzo |
ALX-260-089-M001 |
Proteasome inhibitor I (aldehyde)
|
1mg |
|
|
| Enzo |
ALX-260-089-M005 |
Proteasome inhibitor I (aldehyde)
|
5mg |
|
|